A systems medicine clinical platform for understanding and managing non-communicable diseases

Current Pharmaceutical Design

Volumn 20, Issue 38, 2014, Pages 5945-5956

  Cesario, Alfredo ^a   Auffray, Charles ^b   Agusti, Alvar ^c   Apolone, Giovanni ^d   Balling, Rudi ^e   Barbanti, Piero ^a   Bellia, Alfonso ^f   Boccia, Stefania ^a,g   Bousquet, Jean ^h,i   Cardaci, Vittorio ^a   Cazzola, Mario ^f   Dall’Armi, Valentina ^a   Daraselia, Nikolai ^j   Ros, Lucio Da ^k   Bufalo, Alessandra Del ^a   Ducci, Giuseppe ^l   Ferri, Luigi ^m   Fini, Massimo ^a   Fossati, Chiara ^a   Gensini, Gianfranco ⁿ   Granone, Pierluigi Maria ^g   Kinross, James ^o   Lauro, Davide ^f   Cascio, Gerland Lo ^p   Lococo, Filippo ^d   Lococo, Achille ^q   Maier, Dieter ^r   Marcus, Frederick ^s   Margaritora, Stefano ^n,t   Marra, Camillo ^g   Minati, Gianfranco ^u   Neri, Monica ^a   Pasqua, Franco ^a,v   Pison, Christophe ^w,x   Pristipino, Christian ^y   Roca, Joseph ^c   Rosano, Giuseppe ^a   Rossini, Paolo Maria ^g,z   Russo, Patrizia ^a   Salinaro, Gianluca ^a   Shenhar, Shani ^aa   Soreq, Hermona ^aa   Sterk, Peter J ^ab   Stocchi, Fabrizio ^a   Torti, Margherita ^a   Volterrani, Maurizio ^a   Wouters, Emiel F ^ac   Frustaci, Alessandra ^a   Bonassi, Stefano ^a   more..

^a IRCCS SAN RAFFAELE PISANA   (Italy)

^b UNIVERSITÉ LYON 1   (France)

^c UNIVERSITY OF BARCELONA   (Spain)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e UNIVERSITY OF LUXEMBOURG   (Luxembourg)

^f UNIVERSITY OF ROME TOR VERGATA   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

ⁱ UNIVERSITÉ PARIS SACLAY   (France)

^j ELSEVIER MASSON   (France)

^k Fondazione ITAN Italian Autism Network   (Italy)

^l Rome E Health Authority   (Italy)

^m Department of Imaging   (Italy)

ⁿ UNIVERSITY OF FLORENCE   (Italy)

^o IMPERIAL COLLEGE LONDON   (United Kingdom)

^p San Raffaele Montecompatri   (Italy)

^q SPIRITO SANTO HOSPITAL   (Italy)

^r Biomax Informatics AG   (Germany)

^s San Raffaele Montecompatri ^*  (Italy)

^t CFO Florence Cancer Center   (Italy)

^u Italian Systems Society   (Italy)

^v Unit of San Raffaele Montecompatri   (Italy)

^w GRENOBLE UNIVERSITY HOSPITAL   (France)

^x European Institute for Systems Biology and Medicine EISBM   (France)

^y SAN FILIPPO NERI HOSPITAL   (Italy)

^z IRCSS S Raffaele   (Italy)

^aa HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^ab UNIVERSITY OF AMSTERDAM   (Netherlands)

^ac MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

more..

Author keywords

Non communicable diseases; P4 medicine; Systems biology; Systems medicine

Indexed keywords

ARTICLE; CLINICAL MEDICINE; EPIDEMIOLOGICAL DATA; HUMAN; MEDICAL ETHICS; NON COMMUNICABLE DISEASE; PHENOTYPE; PRIORITY JOURNAL; SYSTEMS BIOLOGY;

EID: 84995527915     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612820666140314130449     Document Type: Article

References (115)

1. Rosenbaum L, Lamas D. Facing a “Slow-Motion Disaster”- The UN Meeting on Noncommunicable Diseases. New Eng J Med 2011; 22: 2345-238.
2. World Health Organization (WHO). Global Status Report on Noncommunicable Diseases 2010. Description of the Global Burden of NCDs, Their Risk Factors and Determinants. Geneva, Switzerland: WHO 2011. Available from: http://whqlibdoc. who. int/publications/2011/9789240686458_eng. pdf.
3. World Health Organization (WHO). 2008-2013 action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva, Switzerland: WHO 2008. Available from: www. who. int/nmh/Actionplan-PC-NCD-2008. pdf.
4. Beaglehole R, Bonita R, Horton R, et al. Lancet NCD Action Group; NCD Alliance. Priority actions for the non-communicable disease crisis. Lancet 2011; 377: 1438-47
5. Wild CP. Complementing the genome with an "exposome": The outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiology Biomarkers & Prevention 2005; 14: 1847-50.
6. Wild C, Scalbert A, Hergec Z. Measuring the Exposome. A Powerful Basis for Evaluating Environmental Exposures and Cancer Risk. Environ Mol Mutagen 2013; 54(7): 480-99. doi: 10. 1002/em. 21777.
7. Nicholson JK, Holmes E, Kinross JM, Darzi AW, Takats Z, Lindon JC. Metabolic phenotyping in clinical and surgical environments. Nature 2012; 491: 384-92
8. Medina MÁ. Systems biology for molecular life sciences and its impact in biomedicine. Cell Mol Life Sci 2013; 70: 1035-53.
9. Louridas GE, Kanonidis IE, Lourida KG. Systems biology in heart diseases. Hippokratia 2010; 14: 10-16.
10. Sun MG, Kim PM. Evolution of biological interaction networks: from models to real data. Genome Biol 2011; 12: 235.
11. Marcus F. Bioinformatics and Systems Biology: Collaborative Research and Resources. Berlin and Heidelberg: Springer-Verlag 2008.
12. Madhavan S, Gusev Y, Harris M, et al. G-DOC: a systems medicine platform for personalized oncology. Neoplasia 2011; 13: 771-83.
13. Auffray C, Chen Z, Hood L. Systems medicine: the future of medical genomics and healthcare. Genome Med 2009; 1: 2.
14. Mardinoglu A, Nielsen J. Systems medicine and metabolic modeling. J Intern Med 2012; 271: 142-54.
15. Hood L, Flores M. A personal view on systems medicine and the emergence of proactive P4 medicine: predictive, preventive, personalized and participatory. N Biotechnol 2012; 29: 613-24.
16. Hood L, Balling R, Auffray C. Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J 2012; 7: 992-1001
17. Lötvall J, Akdis CA, Bacharier LB, et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol 2011; 127: 355-60.
18. Wheelock CE, Goss VM, Balgoma D, et al. The U-BIOPRED Study Group. Application of 'omics technologies to biomarker discovery in inflammatory lung diseases. Eur Respir J 2013; [Epub ahead of print].
19. Nielsen J. Translational and system medicine. J Intern Med 2011; 271: 108-110.
20. Boccia S. Personalized health care: the hope beyond the hype. Italian J Public Health 2012; 9: e8688-1-e8688-2.
21. Bousquet J, Anto JM, Sterk PJ, Adcock IM, et al. Systems medicine and integrated care to combat chronic non communicable diseases. Genome Med 2011; 3: 4.
22. Iris F. Psychiatric systems medicine: closer at hand than anticipated but not with the expected portrait. Pharmacopsychiatry 2012; 1: S12-21.
23. Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi A.. The human disease network. Proc Natl Acad Sci USA 2007; 104: 8685-90.
24. Menon R, Farina C. Shared Molecular and Functional Frameworks among Five Complex Human Disorders: A Comparative Study on Interactomes Linked to Susceptibility Genes. PLoS ONE 2011; 6: e18660.
25. Frisardi V, Solfrizzi V, Seripa D, et al. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Aging Research Review 2010; 9: 339-417.
26. Ray M, Ruan J, Zhang W. Variations in the transcriptome of Alzheimer's disease reveal molecular networks involved in cardiovascular diseases. Genome Biol 2008; 9: R148.
27. Tacutu R, Budovsky A, Yanai H, Fraifeld VE. Molecular links between cellular senescence, longevity and age-related diseases - a systems biology perspective. Aging (Albany NY) 2011; 3: 1178-91.
28. Krichevsky AM, Gabriely G. miR-21: a small multi-faceted RNA. J Cell Mol Med 2009; 13: 39-53.
29. Cazzola M, Calzetta L, Lauro D, et al. Asthma and COPD in an Italian adult population: Role of BMI considering the smoking habit. Respir Med 2013; 107: 1417-22.
30. Cazzola M, Calzetta L, Rogliani P, et al. High glucose enhances responsiveness of human airways smooth muscle via the Rho/ROCK pathway. Am J Respir Cell Mol Biol 2012 Oct; 47: 509-16.
31. Cesario A, Marcus F. Cancer Systems Biology, Bioinformatics and Medicine: Research and Clinical Applications. Dordrecht Heidelberg London and New York: Springer 2011.
32. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013; 187: 728-35.
33. Park J, Lee DS, Christakis NA, Barabási AL. The impact of cellular networks on disease comorbidity. Mol Syst Biol 2009; 5: 262.
34. Roque FS, Jensen PB, Schmock H, et al. Using Electronic Patient Records to Discover Disease Correlations and Stratify Patient Cohorts. PLoS Comput Biol 2011; 7: e1002141.
35. Chaouiya C. Petri net modelling of biological networks. Brief Bioinform 2007; 8: 210-19.
36. Nagasaki M, Doi A, Matsuno H, Miyano S. A versatile Petri net based architecture for modeling and simulation of complex biological processes. Genome Inform 2004; 15: 180-97.
37. Thomas A, Cannings R, Monk NAM, Cannings C. On the structure of protein-protein interaction networks. Biochemical Society Transactions 2003; 31: 1491-6.
38. Jeong H, Tombor B, Albert R, Oltva ZN, Barabási AL.The large-scale organization of metabolic networks. Nature 2000; 407: 651-4.
39. Ravasz E, Somera AL, Mongru DA, Oltvai ZN, Barabási AL. Hierarchical organization of modularity in metabolic networks. Science 2002; 297: 1551-5.
40. Jeong H, Oltvai Z, Barabasi A. Prediction of protein essentiality based on genomic data. Complexus 2003; 1: 19-28.
41. Moretti S, Fragnelli V, Patrone F, Bonassi S. Using coalitional games on biological networks to measure centrality and power of genes. Bioinformatics 2010; 26: 2721-30.
42. Sivachenko AY, Yuryev A, Daraselia N, Mazo I. Molecular networks in microarray analysis. J Bioinform Comput Biol 2007; 5: 429-56.
43. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. ProcNatl Acad Sci USA 2005; 102: 15545-50.
44. Pollard J, Butte AJ, Hoberman S, et al. A computational model to define the molecular causes of type 2 diabetes mellitus. Diabetes Technol Ther 2005; 7: 323-36.
45. Durzinsky M, Wagler A, Weismantel R, Marwan W. Automatic reconstruction of molecular and genetic networks from discrete time series data. Bio Systems 2008; 93: 181-90.
46. Marwan W, Wagler A, Weismantel R. A mathematical approach to solve the network reconstruction problem. Mathematical Methods of Operations Research 2008; 67: 117-32.
47. Galperin MY, Fernández-Suárez XM. The 2012 Nucleic Acids Research Database Issue and the online Molecular Biology Database Collection. Nucl Acids Res 2012; 40: D1-8.
48. Kalra D, Beale T, Heard S. The openEHR Foundation; Stud Health Technol Inform 2005; 115: 153-73.
49. Thorisson GA, Muilu J, Brookes AJ. Genotype-phenotype databases: challenges and solutions for the post-genomic era. Nat Rev Genet 2009; 10: 9-18.
50. Losko S, Heumann K. Semantic data integration and knowledge management to represent biological network associations. Methods Mol Biol 2009; 563: 241-58.
51. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000; 25: 25-9.
52. Burrowes KS, Swan AJ, Warren NJ, Tawhai MH. Towards a virtual lung: multi-scale, multi-physics modelling of the pulmonary system. Philos Trans A Math Phys Eng Sci 2008; 366: 3247-63.
53. Zweigenbaum P, Demner-Fushman D, Yu H, Cohen KB. Frontiers of biomedical text mining: current progress. Brief Bioinform 2007; 8: 358-75.
54. Fortier I, Burton PR, Robson PJ, et al. Quality, quantity and harmony: the DataSHaPER approach to integrating data across bio-clinical studies. Int J Epidemiol 2010; 39: 1383-93.
55. Han MK, Agusti A, Calverley PM, et al. Chronic Obstructive Pulmonary Disease Phenotypes: The Future of COPD. Am J Respir Crit Care Med 2010; 182: 598-604.
56. Muskulus M, Slats AM, Sterk PJ, Verduyn-Lunel S. Fluctuations and determinism of respiratory impedance in asthma and chronic obstructive pulmonary disease. J Appl Physiol 2010; 109: 1582-91.
57. Bousquet J, Anto J, Auffray C, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011; 66: 596-604.
58. Maier D, Kalus W, Wolff M, et al. Knowledge management for systems biology a general and visually driven framework applied to translational medicine. BMC Syst Biol 2011; 5: 38.
59. Orešič M, Lötjönen M, Soininen H. Systems medicine and the integration of bioinformatic tools for the diagnosis of Alzheimer’s disease. Genome Med 2010; 2: 83.
60. Kolodkin A, Simeonidis E, Balling R, Westerhoff HV. Understanding complexity in neurodegenerative diseases: in silico reconstruction of emergence. Front Physiol 2012; 3: 1-10.
61. Linn BS, Linn MW, Gurel L. Cumulative Illness Rating Scale. J Am Geriatr Soc 1968; 16: 622-6.
62. Miller MD, Paradis CF, Houck PR, et al. Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale. Psychiatry Res 1992; 41: 237-48.
63. Folstein MF, Folstein SE, McHugh PR. “Mini Mental State” a practical method for grading the cognitive state of patients for the clinicians. J Psychiat Res 1975; 12: 189-98.
64. Nasreddine Z, Phillips NA, Bédirian V, et al. The Montreal Cognitive Assessment MoCA:, a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-9.
65. Osterrieth PA. Filetest de copie d'une figure complex: Contribution a l'etude de la perception et de la memoire [The test of copying a complex figure: A contribution to the study of perception and memory]. Archives de Psychologie 1994; 30: 286-356.
66. Radloff LS. The CES-D Scale: A self-report depression scale for research in the general population. Applied Psychological Measurement 1977; 1: 385-401.
67. Zung WW. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371-9.
68. Carver CS. You want to measure coping but your protocol’s too long: Consider the Brief COPE. Int J Behav Med 1997; 4: 92-100.
69. Ware JE, Sherbourne CD. The MOS 36-item Short-Form health status survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473-83.
70. Katz TF. A.D.L. Activities of Daily Living. JAMA 1963; 185: 914.
71. Lawton MP, Brody EM. Assessment of older people: Self-maintaining and instrumental activities of daily living. Gerontologist 1969; 9: 179-86.
72. Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med 1991; 85: 25-31.
73. Carone M, Bertolotti G, Anchisi F, Zotti AM, Jones PW, Donner CF. Il Saint George’s Respiratory Questionnaire (SGRQ): la versione Italiana. Rass Mal App Resp 1999; 14: 31-7.
74. Carone M, Bertolotti G, Anchisi F, Zotti AM, Donner CF, Jones PW. Analysis of factors that characterize health impairment in patients with chronic respiratory failure. Quality of Life in Chronic Respiratory Failure Group. Eur Respir J 1999; 13: 1293-300.
75. Vidotto G, Carone M, Jones PW, Salini S, Bertolotti G. Maugeri Respiratory Failure questionnaire reduced form: a method for improving the questionnaire using the Rasch model. Disabil Rehabil 2007; 29: 991-8.
76. Doherty DE, Belfer MH, Brunton AS, Fromer L, Morris CM, Snader TC. Chronic Obstructive Pulmonary Disease: consensus recommendations for early eiagnosis and treatment. J Family Practice 2006; 2-4.
77. American Thoracic Society. ATS Statement: Guidelines for the Six-Minute Walk Test. Am J Respir Crit Care Med 2002; 166: 111-7.
78. Cote CG, Celli BR. BODE index: a new tool to stage and monitor progression of chronic obstructive pulmonary disease. Pneumonol Alergol Pol 2009; 77: 305-13.
79. Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc 1982; 14: 377-81.
80. Mahoney FI, Barthel D. Functional evaluation: the Barthel Index. Maryland State Medical Journal 1965; 14: 56-61.
81. McGuffin P, Farmer A, Harvey I. A polydiagnostic application of operational criteria in studies of psychotic illness: development and reliability of the OPCRIT system. Arch Gen Psychiatry 1991; 48: 764-70.
82. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychological Reports 1962; 10: 799-812.
83. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiat 1960; 23: 56.
84. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-35.
85. Hamilton M. The assessment of anxiety states by rating. Br J Med Psycol 1959; 32: 50.
86. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bull 1987; 13: 261.
87. Stewart WF, Lipton RB, Kolodner K, Liberman JN, Sawyer J. Reliability of the Migraine Disability Assessment (MIDAS) score in a population-based sample of headache sufferers. Cephalalgia 1999; 19: 107-14.
88. Stewart WF, Lipton RB, Whyte J, et al. An international study to assess reliability of the Migraine Disability Assessment (MIDAS) score. Neurology 2000; 53: 988-94.
89. Kosinski M, Bayliss MS, Bjorner JB, et al. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003; 12: 963-74.
90. Scott J, Huskisson EC. Vertical or horizontal visual analogue scales. Ann Rheum Dis 1979; 38: 560.
91. Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: The neuropathic Pain Scale. Neurology 1997; 48: 332-8.
92. Carlesimo GA, Caltagirone C, Gainotti G. The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The group for the standardization of the Mental Deterioration Battery. Eur Neurol 1996; 36: 378-84.
93. Cummings JL, Mega M, Gray K, et al. Neurology 1994; 44: 2308-14.
94. Fahn S, Elton RL. UPDRS Development Committee. Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, Eds. Recent Developments in Parkinson’s Disease. Florham Park, NJ: Macmillan 1987; pp. 153-63.
95. Chaudhuri KR, Pal S, DiMarco A, et al. The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease. J Neurol Neurosurg Psychiatry 2002; 73: 629-35.
96. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540-5.
97. Guy W. ECDEU Assessment Manual for Psychopharmacology. US Department of Heath, Education, and Welfare Public Health Service Alcohol, Drug Abuse, and Mental Health Administration. Rockville: MD 1976.
98. Goetz GG, Nutt GN, Stebbins GT. UDysRS: presentation and clinimetric profile Revision. Movement Disorders 2008; 23: 2398-403.
99. Christenson GA, Faber JR, de Zwann M. Compulsive buying: descriptive characteristics and psychiatric comorbidity. J Clin Psychiatry 1994; 55: 5-11.
100. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007; 130: 1552-65.
101. Chaudhuri KR, Martinez-Martin P, Schapira AHV, et al. An international multicentre pilot study of the first comprehensive self-completed non-motor symptoms questionnaire for Parkinson’s disease: the NMSQuest study. Mov Disord 2006; 21: 916-23.
102. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The Metric Properties of a Novel Non-Motor Symptoms Scale for Parkinson’s Disease: Results from an International Pilot Study. Movement Disorders 2007; 22: 1901-11.
103. Abbruzzese G, Antonini A, Barone P, et al. Linguistic, psychometric validation and diagnostic ability assessment of an Italian version of a 19-item wearing-off questionnaire for wearing-off detection in Parkinson's disease. Neurol Sci 2012; 33: 1319-27.
104. Wenning GK, Tison F, Seppi K, et al. Development and Validation of the Unified Multiple System Atrophy Rating Scale (UMSARS). Movement Disorders 2004; 19: 1391-402.
105. Pagonabarraga J, Kulisevsky J, Llebaria G, et al. Parkinson's disease-cognitive rating scale: A new cognitive scale specific for Parkinson's disease. Movement Disorders 2008; 23: 998-1005.
106. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 1961; 4: 561-71.
107. Jenkinson C, Peto V, Fitzpatrick R, Grcenhall R, Hyman N. Self reported functioning and well being in patients with Parkinson's disease. Comparison of the Short FormHealth Survey (SF-36) and Parkinson Disease Questionnaire (PDQ-39). Age Aging 1995; 24: 505-9.
108. Peto V, Jenkinson C, Fitzpatrick R, Greenhall R. The development of a short measure of functioning and well being for individuals with Parkinson's disease. Quality life Res 1995; 4: 241-8.
109. NCI Best Practices for Biospecimen Resources [homepage on the Internet]. National Cancer Institute, NIH; 2007. Available from: http://biospecimens. cancer. gov/bestpractices/.
110. International Society for Biological and Environmental Repositories (ISBER). Best practices for repositories I: Collection, storage, and retrieval of human biological materials for research. Cell Preserv Technol 2005; 3: 5-48.
111. International Society for Biological and Environmental Repositories (ISBER). 2012 Best Practices for Repositories: Collection, Storage, Retrieval, and Distribution of Biological Materials for Research. Biopreservation and Biobanking 2012; 10: 79-161.
112. Directive 2001/20/Ec Of The European Parliament And Of The Council of 4 April 2001. Official J the European Communities. 1.5.2001; L121: 34-44.
113. Commission Directive 2005/28/EC of 8 April 2005. Official J Eur Union 9.4.2005; L91: 13-9.
114. Decreto legislativo 30 giugno 2003, n. 196. Codice IN Materia di Protezione dei Dati Personali. GU n. 174 del 29-7-2003-Suppl. Ordinario n. 123.
115. Flores M, Glusman G, Brogaard K, Price ND, Hood L. P4 medicine: how systems medicine will transform the healthcare sector and society. Personalized Med 2013; 10: 565-76.